Literature DB >> 21981348

The relationship between DNA methylation and telomere length in dyskeratosis congenita.

Shahinaz M Gadalla1, Hormuzd A Katki, Fatma M Shebl, Neelam Giri, Blanche P Alter, Sharon A Savage.   

Abstract

The regulation of telomere length (TL) is a complex process, requiring the telomerase enzyme complex and numerous regulatory proteins. Epigenetic regulation may also be important in telomere maintenance. Specifically, methylation at subtelomeres is associated with changes in TL in vitro and in mouse models. Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized by exceedingly short telomeres and mutations in telomere biology genes. To understand the interaction between methylation and TL in humans, we measured LINE-1, pericentromeric (NBL2), and subtelomeric (D4Z4) methylation in peripheral blood DNA derived from 40 patients with DC and 51 mutation-negative relatives. Pearson's correlation coefficient and linear regression models were used to evaluate the relationship between age-standardized lymphocyte TL measured by flow FISH and % DNA methylation. No differences in % subtelomeric, LINE-1, or pericentromeric methylation between patients with DC and relatives were noted except for an increase in % subtelomeric methylation in DC patients with a telomerase-complex mutation (TERC, TERT, DKC1, or TCAB1) (63.0% in DC vs. 61.8% in relatives, P = 0.03). Positive correlations between TL and DNA methylation at LINE-1 (r = 0.39, P = 0.01) and subtelomeric (r = 0.32, P = 0.05) sites were present in patients with DC. The positive correlation between TL and % LINE-1 methylation was restricted to TINF2 mutations. In contrast, statistically nonsignificant inverse correlations between TL and % LINE-1 (r = -0.17), subtelomeric (r = -0.20) were present in unaffected relatives. This study suggests an interaction between TL and both subtelomeric and LINE-1 methylation, which may be altered based on mutation status of telomere biology genes. Published 2011. This article is a U.S. Government work and is in the public domain in the USA. Aging Cell
© 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21981348      PMCID: PMC3257380          DOI: 10.1111/j.1474-9726.2011.00755.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  27 in total

1.  Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; June A Peters; Jennifer T Loud; Lisa Leathwood; Ann G Carr; Mark H Greene; Philip S Rosenberg
Journal:  Br J Haematol       Date:  2010-04-30       Impact factor: 6.998

2.  Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.

Authors:  Franklin Zhong; Sharon A Savage; Marina Shkreli; Neelam Giri; Lea Jessop; Timothy Myers; Renee Chen; Blanche P Alter; Steven E Artandi
Journal:  Genes Dev       Date:  2011-01-01       Impact factor: 11.361

3.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

4.  DNA methyltransferases control telomere length and telomere recombination in mammalian cells.

Authors:  Susana Gonzalo; Isabel Jaco; Mario F Fraga; Taiping Chen; En Li; Manel Esteller; María A Blasco
Journal:  Nat Cell Biol       Date:  2006-03-26       Impact factor: 28.824

5.  Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.

Authors:  T J Vulliamy; S W Knight; P J Mason; I Dokal
Journal:  Blood Cells Mol Dis       Date:  2001 Mar-Apr       Impact factor: 3.039

6.  Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood.

Authors:  G S Sasa; A Ribes-Zamora; N D Nelson; A A Bertuch
Journal:  Clin Genet       Date:  2011-04-07       Impact factor: 4.438

Review 7.  Advances in the understanding of dyskeratosis congenita.

Authors:  Amanda J Walne; Inderjeet Dokal
Journal:  Br J Haematol       Date:  2009-02-04       Impact factor: 6.998

8.  Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TIN2.

Authors:  T Vulliamy; R Beswick; M J Kirwan; U Hossain; A J Walne; I Dokal
Journal:  Clin Genet       Date:  2011-01-04       Impact factor: 4.438

9.  A role for heterochromatin protein 1γ at human telomeres.

Authors:  Silvia Canudas; Benjamin R Houghtaling; Monica Bhanot; Ghadir Sasa; Sharon A Savage; Alison A Bertuch; Susan Smith
Journal:  Genes Dev       Date:  2011-08-24       Impact factor: 12.890

Review 10.  A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs.

Authors:  Stefan Schoeftner; Maria A Blasco
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

View more
  15 in total

1.  Epigenetic activation of POTE genes in ovarian cancer.

Authors:  Ashok Sharma; Mustafa Albahrani; Wa Zhang; Christina N Kufel; Smitha R James; Kunle Odunsi; David Klinkebiel; Adam R Karpf
Journal:  Epigenetics       Date:  2019-03-04       Impact factor: 4.528

2.  Variation of DNA methylation in candidate age-related targets on the mitochondrial-telomere axis in cord blood and placenta.

Authors:  B G Janssen; H M Byun; B Cox; W Gyselaers; B Izzi; A A Baccarelli; T S Nawrot
Journal:  Placenta       Date:  2014-07-10       Impact factor: 3.481

3.  Non-telomeric epigenetic and genetic changes are associated with the inheritance of shorter telomeres in mice.

Authors:  Amity R Roberts; Edward Huang; Lincoln Jones; Lucia Daxinger; Suyinn Chong; Emma Whitelaw
Journal:  Chromosoma       Date:  2013-07-18       Impact factor: 4.316

4.  Brain imaging features of children with Hoyeraal-Hreidarsson syndrome.

Authors:  Ming-Jie Zhang; Ya-Xian Cao; Hui-Ying Wu; He-Hong Li
Journal:  Brain Behav       Date:  2021-03-18       Impact factor: 2.708

5.  DNA-methylation-based telomere length estimator: comparisons with measurements from flow FISH and qPCR.

Authors:  Emily E Pearce; Steve Horvath; Shilpa Katta; Casey Dagnall; Geraldine Aubert; Belynda D Hicks; Stephen R Spellman; Hormuzd Katki; Sharon A Savage; Rotana Alsaggaf; Shahinaz M Gadalla
Journal:  Aging (Albany NY)       Date:  2021-06-03       Impact factor: 5.682

6.  Global methylation, oxidative stress, and relative telomere length in biliary atresia patients.

Authors:  Wanvisa Udomsinprasert; Nakarin Kitkumthorn; Apiwat Mutirangura; Voranush Chongsrisawat; Yong Poovorawan; Sittisak Honsawek
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

7.  Characterization and rescue of telomeric abnormalities in ICF syndrome type I fibroblasts.

Authors:  Shiran Yehezkel; Rony Shaked; Shira Sagie; Ron Berkovitz; Hofit Shachar-Bener; Yardena Segev; Sara Selig
Journal:  Front Oncol       Date:  2013-02-28       Impact factor: 6.244

8.  Chromatin remodeling of human subtelomeres and TERRA promoters upon cellular senescence: commonalities and differences between chromosomes.

Authors:  Peter E Thijssen; Elmar W Tobi; Judit Balog; Suzanne G Schouten; Dennis Kremer; Fatiha El Bouazzaoui; Peter Henneman; Hein Putter; P Eline Slagboom; Bastiaan T Heijmans; Silvère M van der Maarel
Journal:  Epigenetics       Date:  2013-04-17       Impact factor: 4.528

9.  Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant glioma.

Authors:  Samrat Roy Choudhury; Yi Cui; Jacob R Milton; Jian Li; Joseph Irudayaraj
Journal:  Clin Epigenetics       Date:  2015-10-07       Impact factor: 6.551

10.  Association between Long Interspersed Nuclear Element-1 Methylation and Relative Telomere Length in Wilms Tumor.

Authors:  Hui-Bo Chang; Ji-Zhen Zou; Cai He; Rui Zeng; Yuan-Yuan Li; Fei-Fei Ma; Zhuo Liu; Hui Ye; Jian-Xin Wu
Journal:  Chin Med J (Engl)       Date:  2015-11-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.